0001752724-19-136099.txt : 20190930 0001752724-19-136099.hdr.sgml : 20190930 20190927181042 ACCESSION NUMBER: 0001752724-19-136099 CONFORMED SUBMISSION TYPE: NPORT-EX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190731 FILED AS OF DATE: 20190930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) CENTRAL INDEX KEY: 0000880859 IRS NUMBER: 760352823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-EX SEC ACT: 1940 Act SEC FILE NUMBER: 811-06463 FILM NUMBER: 191123339 BUSINESS ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 BUSINESS PHONE: 7136261919 MAIL ADDRESS: STREET 1: 11 GREENWAY PLAZA STREET 2: SUITE 1000 CITY: HOUSTON STATE: TX ZIP: 77046 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20031126 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL FUNDS INC /MD/ DATE OF NAME CHANGE: 20000620 FORMER COMPANY: FORMER CONFORMED NAME: AIM INTERNATIONAL MUTUAL FUNDS DATE OF NAME CHANGE: 20000323 0000880859 S000064622 Invesco Oppenheimer Global Focus Fund C000209193 Class R6 C000209194 Class R5 C000209195 Class A C000209196 Class Y C000209197 Class C C000209198 Class R ACCESSION NUMBER: 0001752724-19-135589 NPORT-EX 1 ivzofi687soi73119.htm ivzofi687soi73119.htm - Generated by SEC Publisher for SEC Filing

SCHEDULE OF INVESTMENTS July 31, 2019 Unaudited

    Shares  Value      Shares  Value 
Common Stocks—100.0%    Life Sciences Tools & Services (Continued) 
Consumer Discretionary—34.2%    Wuxi Biologics       
Entertainment—5.9%      Cayman, Inc.1,2    360,500$   3,868,383 
Activision Blizzard,              17,013,230 
Inc.    118,420$   5,771,791  Pharmaceuticals—6.8%     
Electronic Arts, Inc.1   155,080     14,344,900  Bayer AG    186,500     12,113,408 
Nintendo Co. Ltd.    41,900     15,350,950  Bristol-Myers       
      35,467,641  Squibb Co.    324,510     14,411,489 
Interactive Media & Services—17.3%    Novo Nordisk AS,       
Alphabet, Inc. ,        Cl. B    306,444     14,708,285 
Cl. A1    21,948     26,737,054        41,233,182 
Baidu, Inc. ,        Industrials—4.2%     
Sponsored ADR1    76,521     8,547,396  Aerospace & Defense—1.0%   
Facebook, Inc. ,        Rolls-Royce       
Cl. A1    219,980     42,726,715  Holdings plc1    546,320     5,712,350 
Tencent Holdings               
Ltd.    425,600     19,905,474  Professional Services—3.2%   
Yandex NV, Cl. A1    176,250     6,912,525  IHS Markit Ltd.1    301,108     19,397,377 
      104,829,164  Information Technology—32.6%   
Internet & Catalog Retail—11.0%    IT Services—11.6%     
Alibaba Group        Mastercard, Inc. ,       
Holding Ltd. ,        Cl. A    94,660     25,773,078 
Sponsored ADR1    184,998     32,025,004  PayPal Holdings,       
Amazon. com, Inc.1    15,635     29,187,105  Inc.1    279,570     30,864,528 
ASOS plc1    177,510     5,583,783  Twilio, Inc. , Cl. A1    94,590     13,158,415 
      66,795,892        69,796,021 
Financials—9.5%        Semiconductors & Semiconductor   
Capital Markets—0.9%    Equipment—3.0%     
S&P Global, Inc.    22,290     5,459,936  QUALCOMM, Inc.    248,580     18,186,113 
Commercial Banks—8.6%    Software—18.0%     
Citigroup, Inc.    258,830     18,418,343  Alteryx, Inc. , Cl. A1    44,440     5,223,478 
Royal Bank of        Anaplan, Inc.1    162,000     9,224,280 
Scotland Group plc    4,779,620     12,624,717  Autodesk, Inc.1    48,680     7,602,356 
Wells Fargo & Co.    437,390     21,174,050  Nice Ltd. ,       
      52,217,110  Sponsored ADR1    108,850     16,623,572 
        salesforce. com, Inc.1   97,930     15,130,185 
Health Care—17.5%      ServiceNow, Inc.1    102,380     28,399,188 
Biotechnology—4.4%      Splunk, Inc.1    151,900     20,553,589 
BeiGene Ltd. , ADR1   70,384     9,666,538  Zendesk, Inc.1    73,940     6,178,426 
Genmab AS1    90,836     16,743,976        108,935,074 
      26,410,514         
Health Care Equipment & Supplies—3.5%         
Abbott Laboratories   143,190     12,471,849         
Coloplast AS, Cl. B    75,152     8,752,786         
      21,224,635         
Life Sciences Tools & Services—2.8%           
Lonza Group AG1    38,425     13,144,847         

 

1 INVESCO OPPENHEIMER GLOBAL FOCUS FUND

 

SCHEDULE OF INVESTMENTS Unaudited / Continued

        Shares   Value 
  Materials—2.0%        
  Chemicals—2.0%        
  Chr. Hansen Holding        
  AS    136,874                 $   11,924,249 
  Total Common Stocks        
  (Cost $439,576,699)     604,602,488 
                 
  Total           
  Investments,           
  at Value (Cost        
$ 439,576,699)  100.0 %   604,602,488 
  Net Other Assets        
  (Liabilities)      0.0   24,926 
  Net Assets      100.0 %             $   604,627,414 

 

Footnotes to Schedule of Investments
1. Non-income producing security.
2. Security purchased or received in a transaction exempt from registration under the Securities Act of 1933, as
amended (the “1933 Act”). The security may be resold pursuant to an exemption from registration under the
1933 Act, typically to qualified institutional buyers.The aggregate value of these securities at July 31, 2019 was
$3,868,383, which represented 0.64% of the Fund’s Net Assets.

Distribution of investments representing geographic holdings, as a percentage of total investments at value, is as
follows:

Geographic Holdings    Value    Percent 
United States  $   390,394,244     64.6% 
China      74,012,796     12.2  
Denmark      52,129,296     8.6  
United Kingdom      23,920,850     4.0  
Israel      16,623,572     2.8  
Japan      15,350,950     2.5  
Switzerland      13,144,847     2.2  
Germany      12,113,408     2.0  
Russia      6,912,525     1.1  
Total  $   604,602,488     100.0% 

 

2 INVESCO OPPENHEIMER GLOBAL FOCUS FUND

 

NOTES TO SCHEDULE OF INVESTMENTS July 31, 2019 Unaudited

Note 1 – Additional Valuation Information

 The following is a summary of the tiered valuation input levels, as of July 31, 2019.The
level assigned to the securities valuations may not be an indication of the risk or liquidity
associated with investing in those securities. Because of the inherent uncertainties of
valuation, the values reflected in the financial statements may materially differ from the value
received upon actual sale of those investments.

        Level 3—   
    Level 1—  Level 2—  Significant   
    Unadjusted  Other Significant                                           Unobservable             
    Quoted Prices                                                  Observable Inputs                    Inputs  Value 
Assets Table           
Investments, at Value:           
Common Stocks           
Consumer Discretionary  $   166,252,490$   40,840,207$   — $   207,092,697 
Financials      45,052,329     12,624,717    —     57,677,046 
Health Care      36,549,876     69,331,685    —     105,881,561 
Industrials      19,397,377     5,712,350    —     25,109,727 
Information Technology      196,917,208     —     —     196,917,208 
Materials      —     11,924,249    —     11,924,249 
Total Assets  $   464,169,280$   140,433,208$   — $   604,602,488 

 

Forward currency exchange contracts and futures contracts, if any, are reported at their
unrealized appreciation/depreciation at measurement date, which represents the change in
the contract’s value from trade date. All additional assets and liabilities included in the above
table are reported at their market value at measurement date.

3 INVESCO OPPENHEIMER GLOBAL FOCUS FUND